查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1591982

免疫球蛋白產品市場：按類型、ROA、應用分類 - 2025-2030 年全球預測

Immunoglobulin Product Market by Type (IGA, IGD, IGE), ROA (IMIG, IVIG, SCIG), Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年免疫球蛋白產品市值為169.5億美元，預計到2024年將達到189.2億美元，複合年成長率為12.50%，到2030年將達到386.7億美元。

免疫球蛋白產品是主要來自人類血漿的重要生物製藥，用於治療免疫力缺乏和自體免疫疾病。其範圍涵蓋多種治療應用，包括原發性和繼發性免疫力缺乏免疫力缺乏、自體免疫疾病和發炎疾病的治療。免疫球蛋白製劑在增強免疫系統、為免疫力患者提供重要支持方面發揮重要作用，凸顯了對免疫球蛋白製劑的需求。其應用涵蓋神經學、血液學和免疫學等治療領域，最終用途市場涵蓋醫院、診所和居家醫療。根據市場洞察，慢性病盛行率的上升、血漿分餾技術的進步以及對免疫球蛋白治療的認知不斷提高是推動市場成長的關鍵因素。此外，新興市場不斷成長的醫療保健支出為市場擴張提供了開拓的機會。然而，高昂的治療費用、有限的報銷政策以及血源性病原體感染風險等挑戰構成了重大障礙。生產的複雜性和監管環境的嚴格性使市場動態更加複雜。對於希望利用成長潛力的公司來說，創新應集中在改進血漿採集和分級方法、開發重組免疫球蛋白產品以及提高產品穩定性和功效。替代來源的研究和開發，例如植物來源或合成的生產，也可能提供一條有利的途徑。了解因 COVID-19 大流行而影響醫療保健服務的需求模式變化至關重要。由於市場競爭激烈，既有現有企業，也有新參與企業，因此可以透過促進技術共用的策略聯盟和強調個人化免疫球蛋白治療來實現市場差異化。總體而言，儘管面臨挑戰，但在技術進步和越來越多的患者尋求有效治療性介入的推動下，免疫球蛋白市場提供了巨大的機會。

主要市場統計
基準年[2023] 169.5億美元
預測年份 [2024] 189.2億美元
預測年份 [2030] 386.7億美元
複合年成長率（%） 12.50%

市場動態：快速發展的免疫球蛋白產品市場的關鍵市場洞察

免疫球蛋白產品市場正因供需的動態交互作用而轉變。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 免疫力缺乏患者增加
    • 世界老年人口的增加
    • 免疫球蛋白製劑的採用迅速增加
  • 市場限制因素
    • 免疫球蛋白製劑高成本且副作用大
  • 市場機會
    • 免疫球蛋白的持續研究和開發活動
    • 新型和先進的免疫球蛋白產品介紹
  • 市場挑戰
    • 管理機構對產品核可的嚴格規則和規範

波特五力策略工具駕馭免疫球蛋白產品市場

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解免疫球蛋白產品市場的外部影響

外部宏觀環境因素在塑造免疫球蛋白產品市場的表現動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解免疫球蛋白產品市場的競爭狀況

免疫球蛋白產品市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位基質免疫球蛋白產品市場供應商的績效評估

FPNV定位矩陣是評估免疫球蛋白產品市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議繪製免疫球蛋白產品市場的成功之路

免疫球蛋白產品市場的策略分析對於旨在加強其在全球市場的影響力的公司至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 免疫不全症增加
      • 世界各地老年人口不斷增加
      • 免疫球蛋白產品的快速採用
    • 抑制因素
      • 免疫球蛋白產品高成本且副作用大
    • 機會
      • 正在進行的免疫球蛋白研究和開發活動
      • 新型和先進的免疫球蛋白產品介紹
    • 任務
      • 產品核可管理機構的嚴格規則和標準
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章免疫球蛋白產品市場：依類型

  • 伊賀
  • IGD
  • ＩＧＥ
  • IGG
  • IGM

第 7 章按 ROA 分類的免疫球蛋白產品市場

  • 伊米格
  • IVIG
  • SCIG

第8章免疫球蛋白產品市場：依應用分類

  • CIDP
  • 慢性淋巴性白血病
  • 先天性愛滋病
  • 低丙種球蛋白血症
  • 免疫不全症
  • 免疫球蛋白
  • 川崎病
  • 多灶性運動神經病變
  • 重症肌無力

第9章美洲免疫球蛋白產品市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太免疫球蛋白產品市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東和非洲免疫球蛋白產品市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • ADMA Biologics, Inc.
  • Baxter International Inc.
  • Bayer AG
  • Beckman Coulter, Inc.
  • Bio Products Laboratory Ltd.
  • Biotest AG
  • China Biologic Products Holdings, Inc.
  • CSL Limited
  • Emergent BioSolutions Inc.
  • Evolve Biologics Inc.
  • F. Hoffmann-La Roche AG
  • GigaGen, Inc.
  • Grifols, SA
  • Horizon Therapeutics PLC
  • ImmunOs Therapeutics AG
  • Kamada Ltd.
  • Kedrion SpA
  • Leadiant Biosciences, Inc.
  • LFB SA
  • Octapharma AG
  • Pfizer Inc.
  • Sanquin Plasma Products BV
  • Takeda Pharmaceutical Company Limited
Product Code: MRR-43127F7279C5

The Immunoglobulin Product Market was valued at USD 16.95 billion in 2023, expected to reach USD 18.92 billion in 2024, and is projected to grow at a CAGR of 12.50%, to USD 38.67 billion by 2030.

Immunoglobulin products are essential biological products derived primarily from human plasma, used to treat immune deficiencies and autoimmune disorders. Their scope encompasses various therapeutic applications, including management of primary immune deficiencies, secondary immune deficiencies, and autoimmune and inflammatory diseases. The necessity of immunoglobulin products is underscored by their crucial role in bolstering the immune system, offering vital support to patients with compromised immunity. Their applications extend to treatments in neurology, hematology, and immunology, with end-use markets spanning hospitals, clinics, and homecare settings. Market insights reveal that the rising prevalence of chronic diseases, advancements in plasma fractionation technologies, and growing awareness surrounding immunoglobulin therapies are key factors boosting market growth. Additionally, increased healthcare expenditure in developing regions presents untapped opportunities for market expansion. However, challenges such as the high cost of treatment, limited reimbursement policies, and the risk of blood-borne pathogen transmission pose significant barriers. The complexity of production and stringent regulatory landscapes further complicate market dynamics. For businesses aiming to capitalize on potential growth, innovation should focus on improving plasma collection and fractionation methods, developing recombinant immunoglobulin products, and enhancing formulation stability and efficacy. R&D into alternative sources, such as plant-based or synthetic production, may also present lucrative pathways. Understanding the demand pattern shifts, driven by the COVID-19 pandemic's impact on healthcare delivery, is crucial. As the market is moderately competitive with a mix of established players and new entrants, fostering strategic alliances for technology sharing and emphasizing personalized immunoglobulin therapies could provide market differentiation. Overall, despite its challenges, the immunoglobulin market offers significant opportunities, driven by technological advancements and a growing patient population demanding effective therapeutic interventions.

KEY MARKET STATISTICS
Base Year [2023] USD 16.95 billion
Estimated Year [2024] USD 18.92 billion
Forecast Year [2030] USD 38.67 billion
CAGR (%) 12.50%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Immunoglobulin Product Market

The Immunoglobulin Product Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rise in the Cases of Immunodeficiency Diseases
    • Growing Geriatric Population Around the World
    • Surge in the Adoption of Immunoglobulin Products
  • Market Restraints
    • High Cost and Adverse Effects of the Immunoglobulin Products
  • Market Opportunities
    • Ongoing Research and Development Activities in the Immunoglobulin
    • Introduction of New & Advanced Immunoglobulin Products
  • Market Challenges
    • Strict Rules and Norms of Governing Bodies for Product Approval

Porter's Five Forces: A Strategic Tool for Navigating the Immunoglobulin Product Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Immunoglobulin Product Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Immunoglobulin Product Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Immunoglobulin Product Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Immunoglobulin Product Market

A detailed market share analysis in the Immunoglobulin Product Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Immunoglobulin Product Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Immunoglobulin Product Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Immunoglobulin Product Market

A strategic analysis of the Immunoglobulin Product Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Immunoglobulin Product Market, highlighting leading vendors and their innovative profiles. These include ADMA Biologics, Inc., Baxter International Inc., Bayer AG, Beckman Coulter, Inc., Bio Products Laboratory Ltd., Biotest AG, China Biologic Products Holdings, Inc., CSL Limited, Emergent BioSolutions Inc., Evolve Biologics Inc., F. Hoffmann-La Roche AG, GigaGen, Inc., Grifols, S.A., Horizon Therapeutics PLC, ImmunOs Therapeutics AG, Kamada Ltd., Kedrion S.p.A, Leadiant Biosciences, Inc., LFB S.A, Octapharma AG, Pfizer Inc., Sanquin Plasma Products B.V., and Takeda Pharmaceutical Company Limited.

Market Segmentation & Coverage

This research report categorizes the Immunoglobulin Product Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across IGA, IGD, IGE, IGG, and IGM.
  • Based on ROA, market is studied across IMIG, IVIG, and SCIG.
  • Based on Application, market is studied across CIDP, CLL, Congenital AIDS, Hypogammaglobulinemia, Immunodeficiency Diseases, ITP, Kawasaki Disease, Multifocal Motor Neuropathy, and Myasthenia Gravis.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rise in the Cases of Immunodeficiency Diseases
      • 5.1.1.2. Growing Geriatric Population Around the World
      • 5.1.1.3. Surge in the Adoption of Immunoglobulin Products
    • 5.1.2. Restraints
      • 5.1.2.1. High Cost and Adverse Effects of the Immunoglobulin Products
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing Research and Development Activities in the Immunoglobulin
      • 5.1.3.2. Introduction of New & Advanced Immunoglobulin Products
    • 5.1.4. Challenges
      • 5.1.4.1. Strict Rules and Norms of Governing Bodies for Product Approval
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Immunoglobulin Product Market, by Type

  • 6.1. Introduction
  • 6.2. IGA
  • 6.3. IGD
  • 6.4. IGE
  • 6.5. IGG
  • 6.6. IGM

7. Immunoglobulin Product Market, by ROA

  • 7.1. Introduction
  • 7.2. IMIG
  • 7.3. IVIG
  • 7.4. SCIG

8. Immunoglobulin Product Market, by Application

  • 8.1. Introduction
  • 8.2. CIDP
  • 8.3. CLL
  • 8.4. Congenital AIDS
  • 8.5. Hypogammaglobulinemia
  • 8.6. Immunodeficiency Diseases
  • 8.7. ITP
  • 8.8. Kawasaki Disease
  • 8.9. Multifocal Motor Neuropathy
  • 8.10. Myasthenia Gravis

9. Americas Immunoglobulin Product Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Immunoglobulin Product Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Immunoglobulin Product Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. ADMA Biologics, Inc.
  • 2. Baxter International Inc.
  • 3. Bayer AG
  • 4. Beckman Coulter, Inc.
  • 5. Bio Products Laboratory Ltd.
  • 6. Biotest AG
  • 7. China Biologic Products Holdings, Inc.
  • 8. CSL Limited
  • 9. Emergent BioSolutions Inc.
  • 10. Evolve Biologics Inc.
  • 11. F. Hoffmann-La Roche AG
  • 12. GigaGen, Inc.
  • 13. Grifols, S.A.
  • 14. Horizon Therapeutics PLC
  • 15. ImmunOs Therapeutics AG
  • 16. Kamada Ltd.
  • 17. Kedrion S.p.A
  • 18. Leadiant Biosciences, Inc.
  • 19. LFB S.A
  • 20. Octapharma AG
  • 21. Pfizer Inc.
  • 22. Sanquin Plasma Products B.V.
  • 23. Takeda Pharmaceutical Company Limited

LIST OF FIGURES

  • FIGURE 1. IMMUNOGLOBULIN PRODUCT MARKET RESEARCH PROCESS
  • FIGURE 2. IMMUNOGLOBULIN PRODUCT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL IMMUNOGLOBULIN PRODUCT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. IMMUNOGLOBULIN PRODUCT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. IMMUNOGLOBULIN PRODUCT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. IMMUNOGLOBULIN PRODUCT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL IMMUNOGLOBULIN PRODUCT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. IMMUNOGLOBULIN PRODUCT MARKET DYNAMICS
  • TABLE 7. GLOBAL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY IGA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY IGD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY IGE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY IGG, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY IGM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY IMIG, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY IVIG, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY SCIG, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY CIDP, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY CLL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY CONGENITAL AIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY HYPOGAMMAGLOBULINEMIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY IMMUNODEFICIENCY DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ITP, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY KAWASAKI DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY MULTIFOCAL MOTOR NEUROPATHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY MYASTHENIA GRAVIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 51. AUSTRALIA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. AUSTRALIA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. CHINA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. CHINA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
  • TABLE 56. CHINA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. INDIA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. INDIA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
  • TABLE 59. INDIA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. INDONESIA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. INDONESIA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
  • TABLE 62. INDONESIA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. JAPAN IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. JAPAN IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
  • TABLE 65. JAPAN IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. MALAYSIA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. MALAYSIA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
  • TABLE 68. MALAYSIA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. PHILIPPINES IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. PHILIPPINES IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
  • TABLE 71. PHILIPPINES IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. SINGAPORE IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. SINGAPORE IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
  • TABLE 74. SINGAPORE IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. SOUTH KOREA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. SOUTH KOREA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
  • TABLE 77. SOUTH KOREA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. TAIWAN IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. TAIWAN IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
  • TABLE 80. TAIWAN IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. THAILAND IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. THAILAND IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
  • TABLE 83. THAILAND IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. VIETNAM IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. VIETNAM IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
  • TABLE 86. VIETNAM IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. EUROPE, MIDDLE EAST & AFRICA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 91. DENMARK IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. DENMARK IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
  • TABLE 93. DENMARK IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. EGYPT IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. EGYPT IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
  • TABLE 96. EGYPT IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. FINLAND IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. FINLAND IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
  • TABLE 99. FINLAND IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. FRANCE IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. FRANCE IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
  • TABLE 102. FRANCE IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. GERMANY IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. GERMANY IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
  • TABLE 105. GERMANY IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. ISRAEL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. ISRAEL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
  • TABLE 108. ISRAEL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. ITALY IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. ITALY IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
  • TABLE 111. ITALY IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. NETHERLANDS IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. NETHERLANDS IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
  • TABLE 114. NETHERLANDS IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. NIGERIA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. NIGERIA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
  • TABLE 117. NIGERIA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. NORWAY IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. NORWAY IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
  • TABLE 120. NORWAY IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. POLAND IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. POLAND IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
  • TABLE 123. POLAND IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. QATAR IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. QATAR IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
  • TABLE 126. QATAR IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. RUSSIA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. RUSSIA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
  • TABLE 129. RUSSIA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. SAUDI ARABIA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. SAUDI ARABIA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
  • TABLE 132. SAUDI ARABIA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. SOUTH AFRICA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. SOUTH AFRICA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
  • TABLE 135. SOUTH AFRICA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. SPAIN IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. SPAIN IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
  • TABLE 138. SPAIN IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. SWEDEN IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. SWEDEN IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
  • TABLE 141. SWEDEN IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. SWITZERLAND IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. SWITZERLAND IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
  • TABLE 144. SWITZERLAND IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. TURKEY IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. TURKEY IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
  • TABLE 147. TURKEY IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED ARAB EMIRATES IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. UNITED ARAB EMIRATES IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
  • TABLE 150. UNITED ARAB EMIRATES IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 151. UNITED KINGDOM IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. UNITED KINGDOM IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
  • TABLE 153. UNITED KINGDOM IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 154. IMMUNOGLOBULIN PRODUCT MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 155. IMMUNOGLOBULIN PRODUCT MARKET, FPNV POSITIONING MATRIX, 2023